Professional Documents
Culture Documents
October 2018
Table of Content
1. Research Methodology 13
2. Executive Summary 14
3. Strategic Recommendation 16
2
Table of Content
3
Table of Content
4
Table of Content
8.1 Drivers 96
5
Table of Content
6
List of Figures
Figure No. Figure Title Page No.
Figure 15: Usage of Factor IX Per Capita (IU Per Capita)#, 2016 41
Figure 18: Capacity and Throughput of The Largest Fractionators ( In Thousand Liters) 43
Figure 19: Number of Prevalent Cases of COPD, Worldwide, 2015, (in thousands) 44
Figure 20: Number of Deaths By Alzheimer's Diseases and Other Dementias, By Selected Countries, 2016, (Per Million of 44
Population)
7
List of Figures
Figure No. Figure Title Page No.
Figure 22: Global Aged Population (Above 65), By Country, 2017 (% of total) 46
Figure 23: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %) 46
Figure 24: Global Expected Healthcare Industry Outlook 47
Figure 25: Regional Expected Healthcare Industry Growth Rate By Year 2020 47
Figure 26: Key Factors Driving Global Healthcare Industry 48
Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion) 49
Figure 28: Global Blood Plasma Market Share, By Company, 2017 50
Figure 29: Global Blood Plasma Market Size, By Type, 2017 (%) 52
Figure 30: Global Blood Plasma Market Size, By Type, 2023F (%) 53
Figure 31: Global Immunoglobulins Market, By Value, 2013-2017 (USD Billion) 55
8
List of Figures
Figure Figure Title Page No.
No.
Figure 41: Global Factor VIII (Plasmatic), By Value, 2013-2017 (USD Billion) 63
Figure 42: Global Factor VIII (Plasmatic), By Value, 2018-2023 (USD Billion) 63
Figure 43: Global Factor VIII Market, By Volume, 2013-2017 (International Units) 64
Figure 44: Global Factor VIII Market, By Volume, 2018-2023 (International Units) 64
Figure 46: Other Plasma Products Market, By Value, 2013-2017 (USD Billion) 66
Figure 47: Other Plasma Products Market, By Value, 2018-2023 (USD Billion) 66
Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion) 72
Figure 52: North America GDP per capita, current prices, 2013-2023F (In USD) 73
Figure 53: North America population aged 65 and above, 2013-2017 (% of total) 73
Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion) 75
Figure 57: Europe Blood Plasma Market, By Value, 2013-2017 (USD Billion) 77
Figure 59: Europe Population ages 65 years and above (% of total population), 2013-17 78
Figure 60: European Country Population Aged 65 and Above, 2012-2017 (% of Total) 79
9
List of Figures
Figure No. Figure Title Page No.
Figure 61: GDP, Europe Region, By Select Country, 2017 (In Trillion USD) 79
Figure 62: Europe Blood Plasma Market, By Value, 2018-2023 (USD Billion) 80
Figure 63: APAC & Oceania Blood Plasma Market, By Value, 2013-2017 (USD Billion) 82
Figure 64: GDP Per Capita in APAC, By Selected Country, 2013 (In USD) 83
Figure 65: GDP Per Capita in APAC, By Select Country, 2016 (In USD) 83
Figure 66: Population ages 65 and above, By Select Country, 2017 (% of total) 84
Figure 67: Population ages 65 and above, By Select Country, 2050 (% of total) 84
Figure 68: APAC & Oceania Blood Plasma Market, By Value, 2018-2023 (USD Billion) 85
Figure 69: ROW Blood Plasma Market, By Value, 2013-2017 (USD Billion) 87
Figure 70: GDP Per Capita in ROW, By Select Country, 2013 (In USD) 88
Figure 71: GDP Per Capita in ROW, By Select Country, 2017 (In USD) 88
Figure 72: GDP Per Capita in ROW, By Select Country, 2017 (In USD) 89
Figure 74: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total) 90
Figure 75: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %) 90
Figure 76: Middle East and North Africa, Population ages 65 and above (% of total) 91
Figure 77: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion) 91
Figure 78: ROW Blood Plasma Market, By Value, 2018-2023 (USD Billion) 92
10
List of Figure
Figure No. Figure Title Page No.
Figure 81: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %) 98
Figure 82: Global Aged Population(Above 65), (% of total) 99
Figure 86: CSL Limited Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 146
Figure 87: CSL Limited, Sales, By Business Segments, 2017 (In %) 146
Figure 88: CSL Limited, By Geographic Region, 2017 (In %) 146
Figure 89: Baxter International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 148
Figure 90: Baxter International, By Business Segments, 2017 (In %) 148
Figure 91: Baxter International, By Geographic Region, 2017 (In %) 148
Figure 92: Grifols S.A, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 150
Figure 93: Grifols S.A, By Business Segments, 2017 (In %) 150
Figure 94: OCTA Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 152
Figure 95: Emergent Bio-Solutions, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 154
Figure 96: Emergent Bio-Solutions , By Geography, 2017 (In %) 154
Figure 97: Antaris Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 156
Figure 98: AMAG Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 158
Figure 99: Kedrion Bio Pharma, Sales Revenue, 2013-2017 (USD Billion) 160
Figure 100: Kedrion Bio Pharma, Sales Revenue, By Geography, 2017 (%) 160
11
List of Figure
Figure No. Figure Title Page No.
Figure 101: Bio Delivery Science International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 162
Figure 102: Biotest A.G, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 164
12
Research Methodology
For our study on Blood Plasma market, we have conducted comprehensive secondary research followed by
an extensive primary research. In the process of secondary research, we have scrutinized industry
documents, accessed from open sources, premium paid databases and our internal knowledge base. In the
process of primary research, we have interviewed various industry experts across the value chain of the
Blood Plasma.
Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the
industry in the last five years, and confirming the findings through primary research. Annual reports of
the companies are scanned to further validate the market size and to estimate the size of various
segments. Market sizing and growth in the forecast period (2018-2023) is estimated through revenue
mapping, growth of Blood Plasma and historical growth pattern of the industry. All the relevant data
points/ statistics in the forecast period are validated through relevant and reliable primary sources.
13
Global Blood Plasma Market
Rapid increase in the plasma derived treatment procedures has been driving the market
of blood plasma globally.
Figure 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion)
CAGR: 2013-2017
xx%
Xx
Xx
Xx
Xx
14
Global Blood Plasma Market
New plasma protein products coupled with rapidly surging demand from emerging economies are
expected to support the market growth in forecasted period.
Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion)
CAGR: 2018-2023
xx%
Xx
Xx
Xx
Xx
Xx
15
Global Blood Plasma Market- By Type
In 2017, Immunoglobulins holds highest share among all the segments owing to its increase in
the usage of other diseases beside primary immune diseases.
xx
xx
16
Global Blood Plasma Market- By Type
In forecast period, IG is expected to create its dominance, while other segments are expected to
capture a major market proportion due to the introduction of new and specialized plasma products.
xx
xx
17
GlobalImmunoglobulins
Global Insulin Pumps (IVIG+SCIG)
Market, By Market
Value
Figure 31: Global Immunoglobulins Market, By Value, 2013- Figure 32: Global Immunoglobulins Market, By Value,
2017 2018-2023(USD Billion)
(USD Billion)
CAGR 2013-2017 CAGR 2018-2023
xx% xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates
Xx
Xx
Xx
Xx
Xx
18
GlobalImmunoglobulins
Global Insulin Pumps (IVIG+SCIG)
Market, By Market
Value
Figure 33: Global Immunoglobulin Market, By Figure 34: Global Immunoglobulins Market, By
Volume, 2013-2017, Volume (Tons) Volume, 2018-2023(Tons)
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates
Xx
Xx
Xx
Xx
Xx
19
Global Immunoglobulins Market: Company Share
20
North America Blood Plasma Market
Availability of source plasma in abundant quantity has been driving the market of blood plasma in North
America region.
Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion)
CAGR: 2013-2017
xx%
Xx
Xx
Xx
Xx
Xx
21
North America Blood Plasma Market
Rapidly increasing acceptance of new and specialized blood plasma protein products is expected to back
market growth in the region.
Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion)
CAGR: 2018-2023
xx%
Xx
Xx
Xx
Xx
Xx
22
Global U.S.A
Insulin Pumps
Blood Market,
Plasma By Value
Market
Figure 57: USA Blood Plasma Market, By Value, 2013- Figure 58: USA Blood Plasma Market, By Value,
2017 (USD Billion) 2018-2023(USD Billion)
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates
Xx
Xx
Xx
Xx
Xx
Xx
23
About Azoth Analytics Pvt Ltd.
Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy
services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food &
beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic
market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).
24